Learn How to Report the Transurethral Resection Codes for BPH
Not all TUR procedures treat the prostate. Transurethral resection codes are important urologic procedural codes used in the surgical management of benign prostatic hyperplasia (BPH) and complications resulting from prostate surgery. Although all three procedures are performed transurethrally using endoscopic instrumentation, each code represents a distinct clinical indication, operative approach, and reimbursement consideration. Understanding the differences among these procedures is essential for accurate coding, documentation, compliance, and reimbursement. Read on for advice on coding these BPH treatments. Understand the Benign Prostatic Hyperplasia Definition BPH is a noncancerous enlargement of the prostate gland that commonly affects aging men. As the prostate enlarges, it compresses the urethra and obstructs urinary flow. Patients may experience urinary hesitancy, weak stream, nocturia, urinary urgency, incomplete bladder emptying, urinary retention, or recurrent urinary tract infections. When conservative management and medication therapy fail, surgical intervention is often necessary. Resectoscopes used in transurethral resection procedures are classified by electrosurgical energy. There are two types: Get to Know Resection Procedures Code 52601 (Transurethral electrosurgical resection of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included)) describes a transurethral resection of the prostate (TURP). This is considered the gold standard of surgical treatment for moderate to severe BPH. During the procedure, the patient is placed under spinal or general anesthesia. The surgeon inserts a resectoscope through the urethra to the level of the prostate. Using an electrically charged wire loop, obstructive prostate tissue is shaved away in small pieces. Continuous irrigation is used to maintain visualization and evacuate tissue fragments. The goal is to create a wider urethral channel through the prostate, allowing urine to flow freely from the bladder. TURP effectively treats BPH by directly removing the enlarged adenomatous tissue causing obstruction. Following the procedure, most patients experience significant improvement in urinary flow rates, reduction in urinary retention, and relief of lower urinary tract symptoms. Documentation for 52601 should include a BPH with obstruction diagnosis, notes describing failed conservative therapy, operative findings, extent of tissue resection, type of resectoscope used, hemostasis achieved, and postoperative catheter placement if performed. Surgeons should clearly document that prostate tissue was actively resected and removed. Code 52630 (Transurethral resection; residual or regrowth of obstructive prostate tissue including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included)) represents transurethral resection of residual or recurrent obstructive prostate tissue after a previous TURP or similar prostate surgery. This procedure is not considered an initial TURP, but rather a secondary or repeat intervention. Some patients experience regrowth of prostate tissue or incomplete relief after the original surgery, leading to recurrent urinary obstruction months or years later. The operative technique for 52630 is similar to a standard TURP. A resectoscope is introduced through the urethra, and the surgeon removes remaining obstructive tissue using electrocautery. However, coding distinction is based on the patient’s surgical history and the fact that this is a repeat resection procedure. Documentation is particularly important for this code because payers often scrutinize repeat prostate resections. The operative report should clearly identify the patient’s prior prostate surgery, the presence of recurrent obstruction, type of resectoscope, and the residual tissue requiring resection. You need to ensure the documentation supports medical necessity for repeat intervention rather than routine postoperative care. Code 52640 (… of postoperative bladder neck contracture) differs significantly from both 52601 and 52630 because it addresses postoperative bladder neck obstruction or contracture rather than enlarged prostate tissue. A bladder neck contracture may occur as a complication after TURP or other prostate procedures when scar tissue forms between the bladder neck and urethra. The scar tissue narrows the urinary outlet, producing symptoms similar to BPH such as weak stream, urinary retention, and incomplete emptying. During this procedure, the surgeon inserts a resectoscope transurethrally to visualize the bladder neck. The surgeon then incises the scar tissue or resects it using electrocautery or a cutting loop to enlarge the bladder outlet. Unlike TURP, the goal is not removal of prostate adenoma but treatment of scar-related narrowing. Documentation must specifically identify bladder neck contracture, postoperative scarring, or vesicourethral stenosis. The operative note should detail the incision or resection of scar tissue and restoration of bladder outlet patency. Recognize the Importance of Clear Documentation Accurate documentation is critical for all three procedures to support coding compliance and reimbursement. Essential elements include patient symptoms, diagnosis, prior treatment failure, cystoscopic findings, operative technique, type of resectoscope used, tissue removal or incision details, estimated blood loss, complications, and postoperative management. For repeat procedures such as 52630 and 52640, the provider needs to clearly document the patient’s prior surgical history and evidence of recurrent obstruction to establish medical necessity. The three procedures are reimbursed differently based on complexity, physician work, operative time, and postoperative management. Code 52601 generally carries the highest reimbursement because it involves extensive tissue resection and is considered a major definitive surgical treatment for BPH. Medicare and commercial payer reimbursement varies geographically and by facility setting, but physician reimbursement for 52601 is typically significantly higher than office-based, minimally invasive BPH procedures. Code 52630 may reimburse slightly less or similarly to 52601 depending on payer policies. However, reimbursement may be challenged if documentation does not clearly demonstrate recurrent obstruction or prior TURP history. Many payers require evidence that the procedure is medically necessary and not part of routine postoperative management. Code 52640 often carries lower reimbursement than a full TURP because it generally involves treatment of scar tissue rather than extensive prostate resection. Nevertheless, reimbursement remains substantial due to the technical skill required and the potential complexity of managing postoperative contractures. You and your surgeons must ensure that operative reports distinguish bladder neck incision or scar resection from prostate tissue removal to avoid coding errors or denials. Another important reimbursement consideration is the global surgical period. These procedures generally carry a 90-day global period under Medicare guidelines. If additional interventions are required during the postoperative period, modifiers may be necessary to indicate staged, unrelated, or repeat procedures. Proper modifier usage and supporting documentation are essential to prevent reimbursement delays or audits. Remember These Takeaways In summary, codes 52601, 52630, and 52640 represent distinct transurethral procedures used to manage BPH and postoperative urinary obstruction. Code 52601 describes the initial TURP procedure for removal of enlarged prostate tissue causing obstruction. Use 52630 to report repeat resection of recurrent or residual prostate tissue after prior surgery. Assign 52640 when the surgeon addresses bladder neck contracture and scar-related obstruction following prostate surgery. Although all procedures are performed endoscopically through the urethra, each has unique indications, operative goals, documentation requirements, and reimbursement considerations. Accurate coding and detailed operative documentation are essential to support medical necessity, ensure compliance, and optimize reimbursement outcomes. Stephanie N. Stinchcomb Storck, CPC, CPMA, CUC, CCS-P,

longtime urology coding expert, Summerfield, Florida
